ArticleDiscover oncology2025
Systematic pan-cancer analysis of IL3RA carcinogenesis in human tumors, combined with bioinformatics analysis.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond sex determination: the Y chromosome in male cancers.Nature reviews. Cancer · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Previous studies have demonstrated the significance of IL3R in hematological malignancies. Our research has further revealed the impact of IL3RA on the biological behavior of breast cancer cells. However, there is a need for a comprehensive pan-cancer analysis to further elucidate its feasibility. We conducted a thorough analysis of the IL3RA gene's oncogenic role in 33 types of human cancers using datasets from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO). The expression level of IL3RA varies significantly between normal and tumor tissues of different types, and changes in its expression or genetics are closely linked to the prognosis of most cancer patients. In various cancer types, there is also a correlation between the expression of IL3RA and the level of relevant immune cell infiltration. According to the GO and KEGG results, IL3RA plays a significant biological role in regulating various signaling pathways related to the development of the vascular system, angiogenesis, and cell adhesion molecules, among other effects. In summary, the pan-cancer study on IL3RA indicates a strong correlation between the expression level of IL3RA and the onset and prognosis of certain tumors. However, further experimentation and deeper investigation into the underlying mechanisms are necessary to confirm these findings.
Indexed as
Identifiers
41313531What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.